Department of Health Policy

(iStock)

Study finds generic options offer limited savings for expensive drugs

Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.

Speakers discuss use of evidence in state health policymaking

“State Health Policy: Does Evidence Really Make a Difference” was the title of the spring Research into Policy and Practice Lecture, April 11 in Light Hall. The semi-annual lecture is sponsored by the Department of Health Policy.

Study tracks impact of NAS on state Medicaid programs 

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.

Discussing the opioid crises

Stephen Patrick, MD, MPH, MS, assistant professor of Pediatrics and Health Policy in the Division of Neonatology at Monroe Carell Jr. Children’s Hospital at Vanderbilt, testified before Congress recently about the rise and impact of drug withdrawal symptoms in newborns, also known as neonatal abstinence syndrome (NAS).

white pills spilling out of a prescription bottle

Opioid use increases risk of serious infections

Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids.

senior women exercising

Study evaluates community-based health efforts

A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension.

1 7 8 9 10 11 13